Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study of Transplantation of Autologous Adipose Derived Stem Cells (ADSCs) in Completely Acute Spinal Cord Injury.

NCT02034669 is registered in ClinicalTrials.gov with Tri Phuoc Biotechnology., JSC as lead sponsor.

NCT NCT02034669
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02034669 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study of Transplantation of Autologous Adipose Derived Stem Cells (ADSCs) in Completely Acute Spinal Cord Injury.
Lead sponsor
Tri Phuoc Biotechnology., JSC
Phase
Phase 1/2
Overall status
Unknown status
Start date
February 28, 2013
Completion date
March 31, 2015
Enrollment
48 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute spinal cord injury